TrialCancer research2010

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Victoria A Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.